End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
138.7 EUR | -12.74% | -12.74% | -12.74% |
Sales 2024 * | 88.37B 81.7B 121B | Sales 2025 * | 90.78B 83.92B 124B | Capitalization | 364B 336B 497B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 20.37B 30.09B | Net income 2025 * | 23.09B 21.35B 31.52B | EV / Sales 2024 * | 4.04 x |
Net cash position 2024 * | 7B 6.47B 9.55B | Net cash position 2025 * | 21.07B 19.48B 28.77B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
15.9
x | Employees | 131,900 |
Yield 2024 * |
3.19% | Yield 2025 * |
3.33% | Free-Float | 77.07% |
Latest transcript on Johnson & Johnson
1 day | -12.74% | ||
1 week | -12.74% | ||
Current month | -12.74% | ||
1 month | -12.74% | ||
3 months | -12.74% | ||
6 months | -12.74% | ||
Current year | -12.74% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.06% | 682B | |
+30.35% | 586B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B | |
-1.42% | 161B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock